跳至主要内容
临床试验/ISRCTN99841044
ISRCTN99841044已完成3 期

High Or Low Dose Syntocinon® for delay in labour: the HOLDS trial

Birmingham Womens NHS Foundation Trust0 个研究点目标入组 1,500 人开始时间: 2016年8月3日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Nulliparous women with singleton cephalic pregnancy at term (37-42 weeks gestation)
  • 2. Confirmed delay in labour and ruptured membranes for whom the clinical decision has been made to prescribe Syntocinon for augmentation of labour
  • According to NICE guidance [NICE 2014], labour is established when there are regular painful contractions and progressive cervical dilation from 4 cm. Delay is suspected when cervical dilation of < 2 cm in 4 hours occurs once labour is established. Delay is confirmed when progress of <1 cm in 2 hours is found on repeat vaginal examination.

排除标准

  • 1. Multiparous women
  • 2. Nulliparous women who:
  • 2.1. Are undergoing induction of labour
  • 2.2. Have a BMI >40 at booking
  • 2.3. Have a multiple pregnancy
  • 2.4. Have existing cardiac disease, bleeding disorders, diabetes (either pre-existing or gestational), previous uterine surgery
  • 2.5. Have had significant antepartum haemorrhage
  • 2.6. Are under 16 years of age
  • 2.7. Have a known contra-indication to oxytocin therapy as listed in the Summary of marketing Product Characteristics

研究者

发起方
Birmingham Womens NHS Foundation Trust

相似试验